Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 196

Insider sales can be a powerful warning

A company’s directors, particularly executive directors, have more insight into a business than anyone else in the market. Therefore, we are generally sceptical when a company’s board member substantially sells-down their ownership as it can signal a negative outlook for the company. Furthermore, a substantial reduction in a director's equity diminishes their 'skin in the game', which helps align their interests with shareholders.

Skin in the game

In our experience, when management (including directors and senior managers) have equity in the company they are running, it is likely to outperform other comparable businesses. This is particularly the case when the founder maintains a stake in the company. Managers with 'skin in the game', a term famously coined by Warren Buffett, have more exposure to the performance of the company they are running. This creates an inherent incentive for them to act in the interests of the company and its shareholders.

When we assess a company as a prospective investment, we always consider how management’s interests are aligned to its shareholders by evaluating remuneration structures including base salary, bonuses and performance hurdles. Our focus on management’s equity stake in the business also applies to our analysis of IPOs, particularly those businesses that are yet to generate a profit (for more, see my Cuffelinks article, ‘Nine factors to assess in IPOs with no earnings’).

Scrutiny of Appendix 3Y Notices

ASX-listed companies must notify the stock exchange (within five business days) using an Appendix 3Y - Change of Director’s Interest Notice when directors acquire or dispose of its shares.

Appendix 3Y Notices can provide valuable insights and we closely monitor these announcements on potential investments as well as those already in our portfolio. We pay particular attention to share sales by executive directors (such as CEOs) with responsibility for the day-to-day operations. Their decision can sometimes be tantamount to a vote of no confidence in the future prospects and may be a signal for us to sell-out of a holding, or at least seek to understand the rationale for the sale. Conversely, a company’s directors increasing their holding typically indicates a positive outlook and their ongoing commitment.

Director sales

Over the last 12 to 24 months, the market has seen the spectacular collapse of numerous company share prices. In many cases, the share price rout was preceded by significant sell-downs by company directors including:

Bellamy’s Australia (ASX: BAL). Former Managing Director and CEO Laura McBain and then-Chairman Rob Woolley sold 14.2% and 44.2% respectively of their shares in Bellamy’s. The sales in August 2016 for $14.60 were made just days before the stock hit an all-time high of $14.90 a share. The disposal of shares in the former market darling proved a portent of Bellamy’s share price performance with its stock plummeting around 69% off their high to trade around $4.61 each at the time of writing.

Vocus Communications (ASX: VOC). Founder and director of the telco James Spenceley substantially sold-down his stake in the business for $26.7 million in August 2016 before the company downgraded its profit guidance in November. Shares in Vocus are now down 54% from their May 2016 high.

Estia Health (ASX: EHE). After the company missed its profit guidance, director and founder of the aged-care operator and developer, Peter Arvanitis, surprised the market in August 2016 by selling his entire stake in the company (around 10%) for $3.15 a share (which compares to a high of $7.41 earlier in the year), or around $55 million. Simultaneously, Mr Arvanitis resigned as a director. The company’s share price had already declined sharply in the months leading up to Mr Arvanitis’s decision to sell-out and continued its decline with the company cutting its profit outlook in October 2016. Shares in Estia have since recovered to trade around Mr Arvanitis’s sale price.

Research reveals correlation

Our belief that insider sales can be a potent indicator of a company’s future performance was buttressed by recent research. An analysis by stockbroking firm Wilsons (not related to Wilson Asset Management) of Appendix 3Y Notices announced to the ASX in 2016 found that, of the companies whose management sold large parcels of shares, 76% underperformed following the sale with their share prices falling an average of 14% (excluding companies with a market capitalisation of less than $50 million and listed investment companies).

The research also found the larger the value of the shares sold, the greater the risk it would underperform. Interestingly, the disposal of shares of any size by a director holding the position of CEO, CFO and/or COO was correlated to significant underperformance of the share price.

When director selling is a positive

Insider sales are not always an ominous sign and director sales can sometimes be a positive for the company outlook. For example, a director that has sold shares but still holds a large parcel may be motivated to ensure a continuing and positive relationship with the buyer because they want to sell again in the future. Also, when a director is selling shares but leaving ‘something on the table’, it can give us confidence in the future prospects of the company. As an example, the executives at Monadelphous Group (ASX: MND) over the years have generally sold and left money on the table.

 

Chris Stott is Chief Investment Officer of Wilson Asset Management (WAM). This article is general information and does not consider the needs of any individual, and WAM may or may not hold some of the investments mentioned.

 

  •   30 March 2017
  • 1
  •      
  •   

RELATED ARTICLES

When directors sell, should you sell too?

The market loves growth stocks – until it doesn’t

banner

Most viewed in recent weeks

Division 296: the initial moves to make before the windows close

What if the best superannuation strategy isn't about earning more, but acting before your options disappear? Several overlooked planning windows are narrowing, with consequences that can last for decades.

The retirement scorecard: how many of these questions can you answer?

From the maths of retirement, estimating spending and picking the right asset allocation to survive a poor decade, here are the questions every retiree – current or future – should be able to answer for themselves.

Testamentary trusts: Treasury has picked the wrong reading

A decades-old estate planning tool has survived one tax crackdown only to be caught by another. The surprise isn't who the reform is targeting, but who could end up paying the price for drafting choices made years ago.

Superannuation’s structural failings

Politicians are fighting over access to super, but they may be arguing about the wrong thing. The system’s three fundamental flaws have been hiding in plain sight for decades, costing Australians far more than they realise.

Avoid unnecessary CGT with this estate planning clause

A simple estate plan can create a ticking time bomb. One overlooked clause can pit spouses against children, delay inheritances, and potentially leave a family facing an unexpected tax bill worth hundreds of thousands of dollars.

Does an American retirement rule work for Australians?

The 4% rule has survived decades of scrutiny, but Australia's retirement system changes the equation in ways most overlook. Before accepting or rejecting this rule of thumb, it pays to understand what really drives retirement outcomes.

Latest Updates

Superannuation

Bill Kelty: Super can't solve everyone's problems

One of the key figures behind Australia’s superannuation system reflects on how it began, what has changed, and why some of today’s biggest debates may be asking too much of a retirement savings system.

Investment strategies

Rising yields have put bonds back in business

For the past decade, investors were forced to chase income wherever they could find it. With yields now offering competition to dividends, the new challenge is deciding whether they're still being adequately rewarded for risk.

Strategy

Do you want a bucket with that?

Retirees, advisers and super funds all talk about the bucket strategy as if it's one thing. It's not. The differences can be significant, and some may matter far more than investors realise when markets become volatile.

Investment strategies

What The Odyssey can teach us about valuation discipline

Investment temptations are hard to resist in the moment, but successful investing is not about ignoring compelling opportunities or ideas. For value investors, the smart move is to prepare before momentum clouds judgement.

Shares

Does market concentration really mean more risk for investors?

One of the most closely watched trends in global markets has become a growing source of investor concern in recent years. Whether that concern is justified, however, turns out to be a far more complicated question.

Retirement

Retirement in reality - 8 months in

Health goals, new friendships and lingering questions about identity have dominated this month. The experience has challenged widely held beliefs about purpose, belonging and what it really means to leave work behind.

Shares

Stagnation might be OK at this point

Australia's economic problems are hardly a secret. The more interesting question for investors is whether the stock market is as exposed to those problems as commonly assumed, or whether the picture is more nuanced.

Sponsors

Alliances

  • ASA-Logo-RGB-ActiveGreen-web.png

© 2026 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.